Resources Sichenzia Ross Ference Carmel LLP Represents High Roller Technologies, Inc. in $25 Million Registered Direct Offering January 22, 2026 Read More › Sichenzia Ross Ference Carmel LLP Achieves Firm Record Advising on Over 170 Transactions Totaling Over $14 Billion in 2025 January 20, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents BriaCell Therapeutics in $30 Million Public Offering January 15, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $8 Million Registered Direct Offering and Private Placement of Estrella Immunopharma January 8, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents Dominari Securities and American Ventures in $20 Million ELOC and $3 Million Private Placement of MMA.INC January 6, 2026 Read More › Sichenzia Ross Ference Carmel LLP Obtains Dismissal Of Petition For Construction Of Will; Extends Precedent to Third Department, And Obtains Resolution In Favor Of IRA Custodian And Account’s Beneficiaries January 5, 2026 Read More › Sichenzia Ross Ference Carmel LLP Represents Lixte Biotechnology in $4.3 Million Registered Direct Offering December 19, 2025 Read More › Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in $20 Million Underwritten Public Offering of Aduro Clean Technologies December 19, 2025 Read More › Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in Financing Arrangements for Up to $180 Million of Robo.ai Inc. December 19, 2025 Read More › Sichenzia Ross Ference Carmel LLP Represents Avalon GloboCare in its Acquisition of RPM Interactive December 17, 2025 Read More › Sichenzia Ross Ference Carmel LLP Represents Jiuzi Holdings in $4 Million Registered Direct Offering December 17, 2025 Read More › Sichenzia Ross Ference Carmel LLP Represents Lexaria Bioscience Corp. in $3.5 Million Registered Direct Offering December 17, 2025 Read More › Sichenzia Ross Ference Carmel LLP Provides 2025 Firm Update and Introduces Re-Designed Firm Website December 15, 2025 Read More › Sichenzia Ross Ference Carmel LLP Represents Treasure Global in $2.5 Million Registered Direct Offering December 15, 2025 Read More › Sichenzia Ross Ference Carmel LLP Represents Virax Biolabs Group Limited in $5 Million Private Placement December 9, 2025 Read More › Sichenzia Ross Ference Carmel LLP Represents JonesTrading in $100 Million At-the-Market Offering of Armata Pharmaceuticals December 8, 2025 Read More › Sichenzia Ross Ference Carmel LLP Represents RBW Capital Partners in $113.5 Million Private Placement of SMX December 4, 2025 Read More › Sichenzia Ross Ference Carmel LLP Represents FibroBiologics, Inc., in $1.5 Million Registered Direct Offering and Concurrent Private Placement December 2, 2025 Read More › Sichenzia Ross Ference Carmel LLP Represents FibroBiologics, Inc., in $4 Million Registered Direct Offering and Concurrent Private Placement with Purchase Price Paid in Gold December 2, 2025 Read More › Sichenzia Ross Ference Carmel LLP Recognized in 2026 Chambers USA New York Spotlight Guide for Securities Transactions and Securities Litigation December 2, 2025 Read More › Sichenzia Ross Ference Carmel LLP Represents LIXTE Biotechnology in its Acquisition of Liora Technologies November 26, 2025 Read More › 1 2 3 … 82 Next »
